tiprankstipranks
Trending News
More News >
Omega Healthcare (OHI)
NYSE:OHI
Advertisement

Omega Healthcare (OHI) AI Stock Analysis

Compare
3,785 Followers

Top Page

OHI

Omega Healthcare

(NYSE:OHI)

Rating:76Outperform
Price Target:
$46.00
▲(6.63% Upside)
Omega Healthcare's strong financial performance and positive earnings call are the most significant factors contributing to its overall score. The company's robust profitability and cash flow metrics, along with strategic corporate actions, bolster its position. However, technical indicators suggest caution due to potential overbought conditions, and valuation metrics indicate a higher-than-average P/E ratio. Despite these concerns, the high dividend yield remains attractive.
Positive Factors
Earnings
2Q25 earnings beat with improvements in Maplewood and solid investment momentum.
Guidance
Guidance was also bumped ahead of Street driven by aforementioned factors, along with a change in planned debt refinancing away from new equity.
Negative Factors
Liquidity Concerns
Given unexpected GEN liquidity concerns, shares may react negatively with potential Medicaid.
State Regulations
Pennsylvania (4.2% of investments) remains challenging given state regulations.

Omega Healthcare (OHI) vs. SPDR S&P 500 ETF (SPY)

Omega Healthcare Business Overview & Revenue Model

Company DescriptionOmega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
How the Company Makes MoneyOmega Healthcare generates revenue primarily through the leasing of its properties to skilled nursing and assisted living operators. The company typically enters into long-term triple-net leases, where the operators are responsible for property maintenance, taxes, and insurance, allowing Omega to receive a steady rental income. Key revenue streams include rental income from its diversified portfolio of healthcare properties and interest income from mortgages and loans provided to operators. Additionally, Omega may benefit from strategic partnerships with healthcare operators, enhancing its portfolio and occupancy rates, which further contributes to its earnings.

Omega Healthcare Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Positive
The earnings call reflected a predominantly positive outlook with strong financial performance, increased guidance, and robust acquisition activity. However, challenges such as the Genesis bankruptcy and potential Medicare rate cuts highlight areas of concern.
Q2-2025 Updates
Positive Updates
Strong Financial Performance
Second quarter adjusted funds from operations (AFFO) of $0.77 per share and funds available for distribution (FAD) of $0.74 per share. Revenue of $283 million, up from $253 million in the same quarter of 2024.
Increased 2025 AFFO Guidance
Raised and narrowed 2025 AFFO guidance to a range of $3.04 to $3.07 per share, reflecting strong earnings and strategic financial management.
Successful Debt Management
Issued $600 million in 5-year bonds, maintaining strong balance sheet metrics with 95% of debt at fixed rates and a fixed charge coverage ratio of 5.4x.
Robust Acquisition Activity
Completed $605 million in new investments, with $527 million in the second quarter alone, including $344 million investment in 45 care homes in the U.K.
High Portfolio Occupancy Rates
Maplewood portfolio occupancy at 95%, with continued improvements anticipated.
Negative Updates
Genesis Bankruptcy Filing
Genesis filed for Chapter 11 bankruptcy, though Omega expects to receive full contractual rent during the process and is involved in debtor-in-possession financing.
Potential Medicare Rate Cut
A potential 4% Medicare rate cut in 2026 due to increased deficit from new legislation, though historically such cuts have been avoided through legislative action.
Challenges in Staffing and Wages
Continued challenges with staffing, particularly in attracting and retaining Certified Nursing Assistants (CNAs), although general wage increases are now at normal inflationary levels.
Company Guidance
During the Omega Healthcare Investors second quarter 2025 earnings call, the company provided updated guidance reflecting strong financial performance and strategic initiatives. Omega raised and narrowed its 2025 adjusted funds from operations (AFFO) guidance to a range of $3.04 to $3.07 per share, up from the previous $2.95 to $3.01 per share, citing strong revenue and EBITDA growth driven by acquisitions and active portfolio management. The company reported second quarter adjusted funds from operations of $0.77 per share and funds available for distribution (FAD) of $0.74 per share. Revenue for the second quarter was $283 million, up from $253 million in the prior year, while net income increased to $140 million compared to $117 million. Omega also highlighted strong balance sheet metrics, with adjusted annualized EBITDA of nearly $1.2 billion and net funded debt of $4.3 billion. The company continues to focus on expanding its senior housing portfolio, which now consists of 396 facilities, representing 38% of its total portfolio. Additionally, Omega outlined its strategic plans for managing operator partnerships, portfolio mix, and investment pipeline, emphasizing a favorable operating environment and over $2 billion in liquidity with low leverage.

Omega Healthcare Financial Statement Overview

Summary
Omega Healthcare's financial performance is commendable, with strong profitability, moderate revenue growth, and efficient cash conversion. The balance sheet is stable with a healthy mix of debt and equity, supporting continued investment and growth opportunities. While the company performs well in profitability and cash flow, there is room for enhancement in return on equity.
Income Statement
85
Very Positive
Omega Healthcare demonstrates strong profitability with a high gross profit margin of 98.70% and a net profit margin of 41.29% for TTM (Trailing-Twelve-Months), indicating efficient cost management. The revenue growth rate from 2024 to TTM is 3.18%, showing moderate growth. The EBIT margin of 62.80% and EBITDA margin of 91.21% further highlight robust operational efficiency.
Balance Sheet
75
Positive
The company's debt-to-equity ratio is 0.94, reflecting a balanced leverage position. Return on equity (ROE) stands at 9.45%, which is solid but could be improved. The equity ratio is 48.85%, indicating a healthy proportion of equity financing. Overall, the balance sheet reflects stability with a reasonable degree of leverage.
Cash Flow
80
Positive
Omega Healthcare's cash flow shows a positive trajectory with a free cash flow growth rate of 4.06% from 2024 to TTM. The operating cash flow to net income ratio of 1.74 and the free cash flow to net income ratio of 1.74 indicate strong cash conversion efficiency, ensuring the company generates ample cash from its operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.11B1.05B949.74M878.24M1.06B892.38M
Gross Profit1.10B1.04B934.72M862.74M1.05B880.07M
EBITDA1.02B947.11M810.84M1.00B992.70M715.64M
Net Income470.73M406.33M242.18M426.93M416.74M159.33M
Balance Sheet
Total Assets10.55B9.90B9.12B9.41B9.64B9.50B
Cash, Cash Equivalents and Short-Term Investments734.18M518.34M442.81M297.10M20.53M163.53M
Total Debt5.00B4.84B5.07B5.29B5.25B5.17B
Total Liabilities5.36B5.17B5.36B5.60B5.53B5.46B
Stockholders Equity4.99B4.54B3.57B3.61B3.91B3.84B
Cash Flow
Free Cash Flow835.07M749.43M617.74M578.51M627.07M633.14M
Operating Cash Flow835.07M749.43M617.74M625.73M722.14M708.26M
Investing Cash Flow-859.48M-671.16M-770.00K442.85M-524.17M-89.06M
Financing Cash Flow752.80M26.32M-473.31M-789.45M-341.12M-485.55M

Omega Healthcare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price43.14
Price Trends
50DMA
39.05
Positive
100DMA
37.67
Positive
200DMA
36.92
Positive
Market Momentum
MACD
1.03
Positive
RSI
71.63
Negative
STOCH
76.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OHI, the sentiment is Positive. The current price of 43.14 is above the 20-day moving average (MA) of 41.54, above the 50-day MA of 39.05, and above the 200-day MA of 36.92, indicating a bullish trend. The MACD of 1.03 indicates Positive momentum. The RSI at 71.63 is Negative, neither overbought nor oversold. The STOCH value of 76.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OHI.

Omega Healthcare Risk Analysis

Omega Healthcare disclosed 36 risk factors in its most recent earnings report. Omega Healthcare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Omega Healthcare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.61B28.208.36%3.67%50.84%104.44%
76
Outperform
$12.58B26.6110.47%6.27%12.73%23.51%
74
Outperform
$4.58B24.996.66%6.29%6.89%240.70%
70
Neutral
$7.29B-1.51%2.34%11.62%
65
Neutral
$12.74B76.481.97%6.19%15.91%-49.49%
63
Neutral
$7.02B13.29-0.50%6.92%4.08%-25.24%
61
Neutral
$6.15B-7.59%6.69%-7.16%23.40%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OHI
Omega Healthcare
42.73
5.75
15.55%
DOC
Healthpeak Properties
18.39
-2.37
-11.42%
SBRA
Sabra Healthcare REIT
19.03
2.92
18.13%
HR
Healthcare Realty Trust
18.06
1.34
8.01%
CTRE
CareTrust REIT
34.08
5.55
19.45%
AHR
American Healthcare REIT, Inc.
42.72
21.41
100.47%

Omega Healthcare Corporate Events

Business Operations and Strategy
Omega Healthcare Revises Investor Presentation Update
Neutral
Jul 10, 2025

On July 10, 2025, Omega Healthcare Investors, Inc. announced a revision to the Operator Updates slide in its investor presentation, which can be accessed on their website. This update reflects the company’s ongoing efforts to provide transparent and current information to its stakeholders, potentially impacting its operational strategies and market positioning within the healthcare real estate sector.

Private Placements and FinancingBusiness Operations and Strategy
Omega Healthcare Announces $600M Senior Notes Offering
Positive
Jun 11, 2025

On June 10, 2025, Omega Healthcare Investors, Inc. announced the pricing of a $600 million public offering of 5.200% Senior Notes due 2030. The net proceeds of approximately $591.1 million are intended for general corporate purposes, including debt repayment and potential acquisitions in healthcare-related real estate. This move is expected to strengthen Omega’s financial position and support its growth strategy in the healthcare real estate sector.

DividendsRegulatory Filings and Compliance
Omega Healthcare Extends Stock Purchase and Dividend Plan
Positive
Jun 6, 2025

On June 6, 2025, Omega Healthcare Investors, Inc. announced the continuation of its Dividend Reinvestment and Common Stock Purchase Plan by filing a prospectus supplement with the SEC. The plan allows existing stockholders and new investors to purchase common stock and reinvest dividends, with 22,447,054 shares registered for issuance, enhancing investment opportunities and potentially strengthening the company’s market position.

Executive/Board ChangesShareholder Meetings
Omega Healthcare Shareholders Approve Key Proposals
Neutral
Jun 6, 2025

At Omega Healthcare‘s Annual Meeting, shareholders voted on several key proposals, including the election of directors, ratification of Ernst & Young LLP as the independent auditor for fiscal year 2025, approval of executive compensation on an advisory basis, and an amendment to increase the number of authorized shares of common stock. All proposals were approved, and changes to the board’s committee memberships were announced, with Stephen D. Plavin being appointed to the Investment Committee.

Business Operations and Strategy
Omega Healthcare Revises Investor Presentation Update
Neutral
Jun 2, 2025

On June 2, 2025, Omega Healthcare Investors, Inc. announced a revision to the Operator Updates slide in its investor presentation, which is available on their website. This update may affect stakeholders by providing new insights into the company’s operations and potentially influencing its market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025